{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:39Z","timestamp":1792788279753,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2020GXNSFBA159016"],"award-info":[{"award-number":["2020GXNSFBA159016"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Self-funded Medical and Health Research Projects in Guangxi in 2020","award":["Z20201342"],"award-info":[{"award-number":["Z20201342"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-025-01680-9","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:51:07Z","timestamp":1752137467000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["MTHFD1L is a novel prognostic marker and therapeutic target in cutaneous melanoma"],"prefix":"10.1186","volume":"20","author":[{"given":"Xinlian","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangfu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebin","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"6","key":"1680_CR1","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41568-023-00565-7","volume":"23","author":"PP Centeno","year":"2023","unstructured":"Centeno PP, Pavet V, Marais R. The journey from melanocytes to melanoma [J]. Nat Rev Cancer. 2023;23(6):372\u201390.","journal-title":"Nat Rev Cancer"},{"key":"1680_CR2","unstructured":"Institute NC. SEER Cancer Stat Facts: Melanoma of the Skin[EB\/OL]. [Accessed on 2025-03-20]. Available online: https:\/\/seer.cancer.gov\/statfacts\/html\/melan.html"},{"key":"1680_CR3","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ejca.2022.03.008","volume":"170","author":"C Garbe","year":"2022","unstructured":"Garbe C, Amaral T, Peris K, et al. European consensus-based interdisciplinary guideline for melanoma. Part 1: diagnostics: update 2022 [J]. Eur J Cancer. 2022;170:236\u201355.","journal-title":"Eur J Cancer"},{"key":"1680_CR4","doi-asserted-by":"publisher","first-page":"115153","DOI":"10.1016\/j.ejca.2024.115153","volume":"215","author":"C Garbe","year":"2025","unstructured":"Garbe C, Amaral T, Peris K, et al. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2024 [J]. Eur J Cancer. 2025;215:115153.","journal-title":"Eur J Cancer"},{"issue":"2","key":"1680_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s40257-024-00910-y","volume":"26","author":"R Reschke","year":"2025","unstructured":"Reschke R, Enk AH, Hassel JC. Prognostic biomarkers in evolving melanoma immunotherapy [J]. Am J Clin Dermatol. 2025;26(2):213\u201323.","journal-title":"Am J Clin Dermatol"},{"key":"1680_CR6","doi-asserted-by":"crossref","unstructured":"Prodan M, Dema A, Nataras BR et al. Prognostic significance of MiRNA subtypes in melanoma: A survival analysis and correlation with treatment response across patient stages [J]. Biomedicines, 2024, 12(12).","DOI":"10.3390\/biomedicines12122809"},{"issue":"2","key":"1680_CR7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3892\/ol.2024.14824","volume":"29","author":"L Pekarek","year":"2025","unstructured":"Pekarek L, S\u00e1nchez Cedra A, Jaudenes Y, D Y, et al. Paradigm of biomarkers in metastatic melanoma (Review) [J]. Oncol Lett. 2025;29(2):78.","journal-title":"Oncol Lett"},{"key":"1680_CR8","doi-asserted-by":"crossref","unstructured":"Majumder A, Bano S, Nayak KB. The pivotal role of One-Carbon metabolism in neoplastic progression during the aging process [J]. Biomolecules, 2024, 14(11).","DOI":"10.3390\/biom14111387"},{"issue":"11","key":"1680_CR9","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.tem.2024.05.010","volume":"35","author":"Y Qiu","year":"2024","unstructured":"Qiu Y, Xie E, Xu H, et al. One-carbon metabolism shapes T cell immunity in cancer [J]. Trends Endocrinol Metab. 2024;35(11):967\u201380.","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"1680_CR10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2174\/1568009623666230804152603","volume":"24","author":"BS Zheng","year":"2024","unstructured":"Zheng BS, Wang S, Zhang JY, et al. Expression, prognostic value, and immune infiltration of MTHFD family in bladder Cancer [J]. Curr Cancer Drug Targets. 2024;24(2):178\u201391.","journal-title":"Curr Cancer Drug Targets"},{"key":"1680_CR11","doi-asserted-by":"publisher","first-page":"1335785","DOI":"10.3389\/fphar.2024.1335785","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang X, Wang Z. Targeting SHMTs and MTHFDs in cancer: attractive opportunity for anti-tumor strategy [J]. Front Pharmacol. 2024;15:1335785.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1680_CR12","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1186\/s12864-024-10159-8","volume":"25","author":"AM Rork","year":"2024","unstructured":"Rork AM, Bala AS, Renner T. Dynamic evolution of the mTHF gene family associated with primary metabolism across life [J]. BMC Genomics. 2024;25(1):432.","journal-title":"BMC Genomics"},{"key":"1680_CR13","doi-asserted-by":"crossref","unstructured":"Liu H, Ou J, Chen Y et al. Association of maternal folate intake and offspring MTHFD1 and MTHFD2 genes with congenital heart disease [J]. Nutrients, 2023, 15(16).","DOI":"10.3390\/nu15163502"},{"issue":"4","key":"1680_CR14","doi-asserted-by":"publisher","first-page":"e12767","DOI":"10.1111\/jpi.12767","volume":"71","author":"L Cui","year":"2021","unstructured":"Cui L, Zhao X, Jin Z, et al. Melatonin modulates metabolic remodeling in HNSCC by suppressing MTHFD1L-formate axis [J]. J Pineal Res. 2021;71(4):e12767.","journal-title":"J Pineal Res"},{"issue":"18","key":"1680_CR15","doi-asserted-by":"publisher","first-page":"e202200274","DOI":"10.1002\/cmdc.202200274","volume":"17","author":"ER Scaletti","year":"2022","unstructured":"Scaletti ER, Gustafsson Westergren R, Andersson Y, et al. The first structure of human MTHFD2L and its implications for the development of Isoform-Selective inhibitors [J]. ChemMedChem. 2022;17(18):e202200274.","journal-title":"ChemMedChem"},{"issue":"4","key":"1680_CR16","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1007\/s12079-023-00779-2","volume":"17","author":"G Khalili-Tanha","year":"2023","unstructured":"Khalili-Tanha G, Mohit R, Asadnia A, et al. Identification of ZMYND19 as a novel biomarker of colorectal cancer: RNA-sequencing and machine learning analysis [J]. J Cell Commun Signal. 2023;17(4):1469\u201385.","journal-title":"J Cell Commun Signal"},{"issue":"1","key":"1680_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/2211-5463.13024","volume":"11","author":"CQ Wang","year":"2021","unstructured":"Wang CQ, Wang XM, Li BL, et al. Arbutin suppresses osteosarcoma progression via miR-338-3p\/MTHFD1L and inactivation of the akt\/mtor pathway [J]. FEBS Open Bio. 2021;11(1):289\u201399.","journal-title":"FEBS Open Bio"},{"key":"1680_CR18","doi-asserted-by":"crossref","unstructured":"Zhu W, Wang C, Xue L et al. The SMYD3-MTHFD1L-formate metabolic regulatory axis mediates mitophagy to inhibit M1 polarization in macrophages [J]. Int Immunopharmacol, 2022, 113(Pt A): 109352.","DOI":"10.1016\/j.intimp.2022.109352"},{"issue":"3","key":"1680_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.tranon.2017.03.002","volume":"10","author":"S Bystr\u00f6m","year":"2017","unstructured":"Bystr\u00f6m S, Fredolini C, Edqvist PH, et al. Affinity proteomics exploration of melanoma identifies proteins in serum with associations to T-Stage and recurrence [J]. Transl Oncol. 2017;10(3):385\u201395.","journal-title":"Transl Oncol"},{"key":"1680_CR20","doi-asserted-by":"crossref","unstructured":"Tang Z, Kang B, Li C, et al. Nucleic Acids Res. 2019;47(W1):W556\u201360. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis [J].","DOI":"10.1093\/nar\/gkz430"},{"key":"1680_CR21","unstructured":"Gordon M, Lumley T. (2023) forestplot: Advanced Forest Plot Using \u2018grid\u2019 Graphics. R package version 3.1.3. https:\/\/CRAN.R-project.org\/package=forestplot"},{"issue":"1","key":"1680_CR22","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets [J]. Nat Commun. 2019;10(1):1523.","journal-title":"Nat Commun"},{"issue":"11","key":"1680_CR23","doi-asserted-by":"publisher","first-page":"e0294236","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang D, Chen M, Huang X, et al. SRplot: A free online platform for data visualization and graphing [J]. PLoS ONE. 2023;18(11):e0294236.","journal-title":"PLoS ONE"},{"issue":"D1","key":"1680_CR24","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest [J]. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"},{"key":"1680_CR25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, et al. Profiling tumor infiltrating immune cells with CIBERSORT [J]. Methods Mol Biol. 2018;1711:243\u201359.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"1680_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape [J]. Genome Biol. 2017;18(1):220.","journal-title":"Genome Biol"},{"issue":"10400","key":"1680_CR27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","volume":"402","author":"GV Long","year":"2023","unstructured":"Long GV, Swetter SM, Menzies AM, et al. Cutaneous melanoma [J]. Lancet. 2023;402(10400):485\u2013502.","journal-title":"Lancet"},{"issue":"5","key":"1680_CR28","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1001\/jamadermatol.2023.0127","volume":"159","author":"M Kashani-Sabet","year":"2023","unstructured":"Kashani-Sabet M, Leachman SA, Stein JA, et al. Early detection and prognostic assessment of cutaneous melanoma: consensus on optimal practice and the role of gene expression profile testing [J]. JAMA Dermatol. 2023;159(5):545\u201353.","journal-title":"JAMA Dermatol"},{"issue":"11","key":"1680_CR29","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/j.tranon.2019.07.011","volume":"12","author":"S Agarwal","year":"2019","unstructured":"Agarwal S, Behring M, Hale K, et al. MTHFD1L, A folate cycle enzyme, is involved in progression of colorectal Cancer [J]. Transl Oncol. 2019;12(11):1461\u20137.","journal-title":"Transl Oncol"},{"issue":"14","key":"1680_CR30","doi-asserted-by":"publisher","first-page":"4213","DOI":"10.7150\/jca.35014","volume":"11","author":"Z He","year":"2020","unstructured":"He Z, Wang X, Zhang H, et al. High expression of folate cycle enzyme MTHFD1L correlates with poor prognosis and increased proliferation and migration in colorectal cancer [J]. J Cancer. 2020;11(14):4213\u201321.","journal-title":"J Cancer"},{"issue":"1","key":"1680_CR31","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jaad.2024.09.035","volume":"92","author":"Y Sun","year":"2025","unstructured":"Sun Y, Shen Y, Liu Q, et al. Global trends in melanoma burden: A comprehensive analysis from the global burden of disease study, 1990\u20132021 [J]. J Am Acad Dermatol. 2025;92(1):100\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"1680_CR32","doi-asserted-by":"publisher","first-page":"737399","DOI":"10.3389\/fonc.2021.737399","volume":"11","author":"A Buja","year":"2021","unstructured":"Buja A, Bardin A, Damiani G, et al. Prognosis for cutaneous melanoma by clinical and pathological profile: A Population-Based study [J]. Front Oncol. 2021;11:737399.","journal-title":"Front Oncol"},{"issue":"12","key":"1680_CR33","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jamadermatol.2023.4193","volume":"159","author":"EC Paver","year":"2023","unstructured":"Paver EC, Ahmed T, Burke H, et al. Prognostic significance of incipient ulceration in primary cutaneous melanoma [J]. JAMA Dermatol. 2023;159(12):1359\u201367.","journal-title":"JAMA Dermatol"},{"issue":"5","key":"1680_CR34","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/ijc.32930","volume":"147","author":"PD Baade","year":"2020","unstructured":"Baade PD, Whiteman DC, Janda M, et al. Long-term deaths from melanoma according to tumor thickness at diagnosis [J]. Int J Cancer. 2020;147(5):1391\u20136.","journal-title":"Int J Cancer"},{"issue":"12","key":"1680_CR35","doi-asserted-by":"publisher","first-page":"e14512","DOI":"10.1111\/jfbc.14512","volume":"46","author":"GH Mello","year":"2022","unstructured":"Mello GH, D\u2019\u00c1vila C M D S, Viana AR, et al. Cocoa presents cytotoxicity against melanoma cancer cell lines (A-375 e B16-F10) and improves chemotherapy activity by increasing oxidative stress [J]. J Food Biochem. 2022;46(12):e14512.","journal-title":"J Food Biochem"},{"key":"1680_CR36","doi-asserted-by":"crossref","unstructured":"Chen J, Yang J, Xu Q et al. Integrated bioinformatics analysis identified MTHFD1L as a potential biomarker and correlated with immune infiltrates in hepatocellular carcinoma [J]. Biosci Rep, 2021, 41(2).","DOI":"10.1042\/BSR20202063"},{"issue":"6","key":"1680_CR37","doi-asserted-by":"publisher","first-page":"e1327004","DOI":"10.1080\/23723556.2017.1327004","volume":"4","author":"D Lee","year":"2017","unstructured":"Lee D, Wong CC. The folate cycle is a new metabolic weakness of cancer [J]. Mol Cell Oncol. 2017;4(6):e1327004.","journal-title":"Mol Cell Oncol"},{"issue":"11","key":"1680_CR38","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.tranon.2019.07.012","volume":"12","author":"ML Eich","year":"2019","unstructured":"Eich ML, Rodriguez Pena MDC, Chandrashekar DS, et al. Expression and role of methylenetetrahydrofolate dehydrogenase 1 like (MTHFD1L) in bladder Cancer [J]. Transl Oncol. 2019;12(11):1416\u201324.","journal-title":"Transl Oncol"},{"key":"1680_CR39","doi-asserted-by":"crossref","unstructured":"Qiao Z, Li Y, Li S, et al. Hypoxia-induced SHMT2 protein lactylation facilitates Glycolysis and stemness of esophageal cancer cells [J]. Mol Cell Biochem; 2024.","DOI":"10.1007\/s11010-023-04913-x"},{"issue":"1","key":"1680_CR40","doi-asserted-by":"publisher","first-page":"113584","DOI":"10.1016\/j.yexcr.2023.113584","volume":"427","author":"J Zhou","year":"2023","unstructured":"Zhou J, Yang Y, Cheng J, et al. MTHFD1L confers a poor prognosis and malignant phenotype in esophageal squamous cell carcinoma by activating the ERK5 signaling pathway [J]. Exp Cell Res. 2023;427(1):113584.","journal-title":"Exp Cell Res"},{"key":"1680_CR41","doi-asserted-by":"publisher","first-page":"101869","DOI":"10.1016\/j.tice.2022.101869","volume":"77","author":"D Yi","year":"2022","unstructured":"Yi D, Yilihamu Y, Jiang C, et al. MTHFD1L knockdown diminished cells growth in papillary thyroid cancer [J]. Tissue Cell. 2022;77:101869.","journal-title":"Tissue Cell"},{"key":"1680_CR42","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.3389\/fonc.2019.01278","volume":"9","author":"H Li","year":"2019","unstructured":"Li H, Fu X, Yao F, et al. MTHFD1L-Mediated redox homeostasis promotes tumor progression in tongue squamous cell carcinoma [J]. Front Oncol. 2019;9:1278.","journal-title":"Front Oncol"},{"issue":"3","key":"1680_CR43","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.21037\/tcr-20-2798","volume":"10","author":"L Zhao","year":"2021","unstructured":"Zhao L, Cheng Z, Lu Z, et al. NAD-dependent methylenetetrahydrofolate dehydrogenase inhibits oral squamous cell carcinoma cell proliferation and promotes apoptosis [J]. Transl Cancer Res. 2021;10(3):1457\u201369.","journal-title":"Transl Cancer Res"},{"issue":"6","key":"1680_CR44","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1080\/10799893.2020.1769658","volume":"40","author":"L Wang","year":"2020","unstructured":"Wang L, Yang Y, Wang XM, et al. MTHFD1L as a folate cycle enzyme correlates with prognostic outcome and its knockdown impairs cell invasive behaviors in osteosarcoma via mediating the akt\/mtor pathway [J]. J Recept Signal Transduct Res. 2020;40(6):584\u201390.","journal-title":"J Recept Signal Transduct Res"},{"issue":"1","key":"1680_CR45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12943-022-01569-x","volume":"21","author":"D Peng","year":"2022","unstructured":"Peng D, Fu M, Wang M, et al. Targeting TGF-\u03b2 signal transduction for fibrosis and cancer therapy [J]. Mol Cancer. 2022;21(1):104.","journal-title":"Mol Cancer"},{"issue":"1","key":"1680_CR46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13045-022-01349-6","volume":"15","author":"X Shi","year":"2022","unstructured":"Shi X, Yang J, Deng S, et al. TGF-\u03b2 signaling in the tumor metabolic microenvironment and targeted therapies [J]. J Hematol Oncol. 2022;15(1):135.","journal-title":"J Hematol Oncol"},{"key":"1680_CR47","doi-asserted-by":"publisher","first-page":"e18887","DOI":"10.7717\/peerj.18887","volume":"13","author":"Q Wang","year":"2025","unstructured":"Wang Q, Shi Y, Qin Z, et al. A375 melanoma-derived lactate controls A375 melanoma phenotypes by inducing macrophage M2 polarization via TCA cycle and TGF-\u03b2 signaling [J]. PeerJ. 2025;13:e18887.","journal-title":"PeerJ"},{"issue":"4","key":"1680_CR48","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3892\/ol.2022.13251","volume":"23","author":"N Niu","year":"2022","unstructured":"Niu N, Zeng J, Ke X, et al. ATIC facilitates cell growth and migration by upregulating Myc expression in lung adenocarcinoma [J]. Oncol Lett. 2022;23(4):131.","journal-title":"Oncol Lett"},{"issue":"25","key":"1680_CR49","doi-asserted-by":"publisher","first-page":"e2301264","DOI":"10.1002\/advs.202301264","volume":"10","author":"C Tang","year":"2023","unstructured":"Tang C, Ke M, Yu X, et al. GART functions as a novel methyltransferase in the RUVBL1\/\u03b2-Catenin signaling pathway to promote tumor stemness in colorectal Cancer [J]. Adv Sci (Weinh). 2023;10(25):e2301264.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"1680_CR50","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1111\/cas.15982","volume":"114","author":"Y Yang","year":"2023","unstructured":"Yang Y, Zhang M, Zhao Y, et al. HOXD8 suppresses renal cell carcinoma growth by upregulating SHMT1 expression [J]. Cancer Sci. 2023;114(12):4583\u201395.","journal-title":"Cancer Sci"},{"issue":"2","key":"1680_CR51","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s43018-022-00331-y","volume":"3","author":"N Bonagas","year":"2022","unstructured":"Bonagas N, Gustafsson NMS, Henriksson M, et al. Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress [J]. Nat Cancer. 2022;3(2):156\u201372.","journal-title":"Nat Cancer"},{"issue":"23","key":"1680_CR52","doi-asserted-by":"publisher","first-page":"21106","DOI":"10.1021\/acs.jmedchem.4c01775","volume":"67","author":"HH Chang","year":"2024","unstructured":"Chang HH, Lee LC, Hsu T, et al. Development of potent and selective inhibitors of methylenetetrahydrofolate dehydrogenase 2 for targeting acute myeloid leukemia: SAR, structural insights, and biological characterization [J]. J Med Chem. 2024;67(23):21106\u201325.","journal-title":"J Med Chem"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01680-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-025-01680-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01680-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T05:48:42Z","timestamp":1757224122000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-025-01680-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1680"],"URL":"https:\/\/doi.org\/10.1186\/s13000-025-01680-9","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the clinical samples were obtained from the Laboratory of the Guangxi Medical University Cancer Hospital. Patient Consent Forms were obtained according to protocols approved by the Institutional Review Board of the Guangxi Medical University Cancer Hospital (KY2023842). Moreover, this study obtained written informed consent from the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}